Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ALUR

Allurion Technologies (ALUR) Stock Price, News & Analysis

Allurion Technologies logo

About Allurion Technologies Stock (NYSE:ALUR)

Key Stats

Today's Range
$0.55
$0.60
50-Day Range
$0.58
$15.15
52-Week Range
$0.23
$3.33
Volume
25,789 shs
Average Volume
1.45 million shs
Market Capitalization
$8.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00
Consensus Rating
Hold

Company Overview

Allurion Technologies is a medical technology company specializing in non-surgical weight-loss solutions. The company’s flagship product, the Allurion Gastric Balloon, is a swallowable, fluid-filled device designed to promote weight loss by creating a sense of fullness in the stomach. Unlike traditional intragastric balloons, the Allurion device does not require endoscopic insertion or removal, as it self-deflates and is naturally expelled after treatment, simplifying the patient experience and reducing clinical resource requirements.

In addition to its gastric balloon, Allurion has developed a comprehensive digital health platform that integrates wireless tracking devices, a mobile application, and remote coaching to support patients throughout their weight-loss journey. The platform provides real-time data on body composition, dietary intake, and physical activity, enabling healthcare providers to monitor patient progress and tailor interventions accordingly. This holistic approach combines medical devices with data-driven behavioral support.

Founded in the early 2010s and headquartered in Natick, Massachusetts, Allurion Technologies has expanded its operations globally, offering its weight-loss solution in multiple markets across North America, Europe, the Middle East, and Asia. The company collaborates with physicians, hospitals, and wellness centers to deliver its programs and has secured regulatory approvals in key jurisdictions, including CE mark certification and other local clearances. Allurion’s strategic partnerships with clinics and healthcare networks aim to make non-surgical weight management more accessible to a wider patient population.

Allurion Technologies continues to invest in research and development to advance its product pipeline and digital offerings. By combining minimally invasive medical devices with a connected health ecosystem, the company seeks to address the growing challenge of obesity and related metabolic conditions through scalable, patient-centric solutions.

AI Generated. May Contain Errors.

Allurion Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

ALUR MarketRank™: 

Allurion Technologies scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Allurion Technologies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Allurion Technologies has a consensus price target of $45.00, representing about 7,658.6% upside from its current price of $0.58.

  • Amount of Analyst Coverage

    Allurion Technologies has received no research coverage in the past 90 days.

  • Read more about Allurion Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Allurion Technologies are expected to grow in the coming year, from ($9.96) to ($7.39) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Allurion Technologies is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Allurion Technologies is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Allurion Technologies' valuation and earnings.
  • Short Interest

    There is no current short interest data available for ALUR.
  • Dividend Yield

    Allurion Technologies does not currently pay a dividend.

  • Dividend Growth

    Allurion Technologies does not have a long track record of dividend growth.

  • Search Interest

    2 people have searched for ALUR on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Allurion Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Allurion Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.10% of the stock of Allurion Technologies is held by insiders.

  • Percentage Held by Institutions

    21.39% of the stock of Allurion Technologies is held by institutions.

  • Read more about Allurion Technologies' insider trading history.
Receive ALUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allurion Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALUR Stock News Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
Allurion Advances Plan to Re-List
See More Headlines

ALUR Stock Analysis - Frequently Asked Questions

Allurion Technologies, Inc. (NYSE:ALUR) posted its quarterly earnings data on Wednesday, November, 12th. The company reported ($17.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($36.75) by $19.05. The company had revenue of $2.66 million for the quarter, compared to analysts' expectations of $2.05 million.
Read the conference call transcript
.

Shares of Allurion Technologies reverse split on the morning of Friday, January 3rd 2025.The 1-25 reverse split was announced on Tuesday, December 24th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 2nd 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Allurion Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Nuvation Bio (NUVB), Taiwan Semiconductor Manufacturing (TSM), Advanced Micro Devices (AMD), Amprius Technologies (AMPX) and Applied Digital (APLD).

Company Calendar

Last Earnings
11/12/2025
Today
8/15/2026
Next Earnings (Estimated)
8/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:ALUR
Previous Symbol
NYSE:ALUR
CIK
1964979
Fax
N/A
Employees
501
Year Founded
2009

Price Target and Rating

High Price Target
$45.00
Low Price Target
$45.00
Potential Upside/Downside
+7,658.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.20 million
Net Margins
-199.96%
Pretax Margin
-184.06%
Return on Equity
N/A
Return on Assets
-77.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.26
Quick Ratio
0.94

Sales & Book Value

Annual Sales
$17.21 million
Price / Sales
0.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($30.08) per share
Price / Book
-0.02

Miscellaneous

Outstanding Shares
14,994,000
Free Float
11,284,000
Market Cap
$8.70 million
Optionable
No Data
Beta
-0.13

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NYSE:ALUR) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners